唾液检测在心血管疾病诊疗中的应用(3)
[8] OZBAY Y， AYDIN S， DAGLIAF， et al. Obestatin is present in saliva： alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease[J]. Bmb Rep，2008，41(1)：55-61.
[9] MALATHI N， MYTHILI S， VASANTHI H R. Salivary diagnostics： a brief review[J]. ISRN dentistry， 2014， 2014.
[10] RATHNAYAKE N， KLINGE B， SORSA T， et al. Cardiovascular disease biomarkers in saliva and plasma[A]. Iadr General Session and Exhibition[C]：2014.
, http://www.100md.com
[11] MIRZAII-DIZGAH I， RIAHI E. Salivary troponin I as an indicator of myocardial infarction[J]. The Indian journal of medical research， 2013， 138(6)： 861.
[12] AN K， SALYER J， KAO HFS. Psychological strains， salivary biomarkers， and risks for coronary heart disease among hurricane survivors[J]. Biological research for nursing， 2014： 1099800414551164.
[13] PUNYADEERA C， DIMESKI G， KOSTNER K， et al. One-step homogeneous C-reactive proteinassay for saliva[J]. J Immunol Methods， 2011：1-2，19-25.
, 百拇医药
[14] FOO J Y， WAN Y， KOSTNER K， et al. NT-ProBNP levels in saliva and its clinical relevance to heart failure[J]. PLoS One，2012，7(10)：448-452.
[15] DENVER R， TZANIDIS A， MARTINP， et al. Salivary endothelin concentrations in the assessment of chronic heart failure[J].The Lancet， 2000， 9202： 468-469.
[16] GURUSANKAR R， KUMARATHASAN P， SARAVANAMUTHU A， et al. Correlation between Saliva and Plasma Levels of Endothelin Isoforms ET-1， ET-2， and ET-3[J]. Int J Pept，2015：828759.
, http://www.100md.com
[17] PUNYADEERA C. New frontiers in heart failure detection： saliva testing[J]. Bmj Innovations， 2016：bmjinnov-2015-000105.
[18] ZHANG X， SCHULZ B L， PUNYADEERA C. The current status of heart failure diagnostic biomarkers[J]. Expert Review of Molecular Diagnostics， 2016，16(4)：487.
[19] FLORIANO P N， CHRISTODOULIDES N， MILLERCS， et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care： a feasibility study[J]. Clinical chemistry， 2009， 55(8)： 1530-1538.
, 百拇医药
[20] EBERSOLE J L， KRYSCIO R J， CAMPBELL C， et al. Salivary and serum adiponectin and C-reactive protein levels in acute myocardial infarction related to body mass index and oral health[J]. Journal of Periodontal Research， 2016，52(3)：419.
[21] MIRZAII-DIZGAH I， HEJAZI S F， RIAHI E，et al. Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction[J]. Clin Oral Investig，2012，16(3)：775-779.
[22] MILLER C S， RD F J， FLORIANO P N， et al. Utility of salivary biomarkers for demonstrating acute myocardial infarction[J]. Journal of Dental Research， 2014，93(7 Suppl)：72S., 百拇医药(李琳 杜佳 凌智 胡志希 李杰)
[9] MALATHI N， MYTHILI S， VASANTHI H R. Salivary diagnostics： a brief review[J]. ISRN dentistry， 2014， 2014.
[10] RATHNAYAKE N， KLINGE B， SORSA T， et al. Cardiovascular disease biomarkers in saliva and plasma[A]. Iadr General Session and Exhibition[C]：2014.
, http://www.100md.com
[11] MIRZAII-DIZGAH I， RIAHI E. Salivary troponin I as an indicator of myocardial infarction[J]. The Indian journal of medical research， 2013， 138(6)： 861.
[12] AN K， SALYER J， KAO HFS. Psychological strains， salivary biomarkers， and risks for coronary heart disease among hurricane survivors[J]. Biological research for nursing， 2014： 1099800414551164.
[13] PUNYADEERA C， DIMESKI G， KOSTNER K， et al. One-step homogeneous C-reactive proteinassay for saliva[J]. J Immunol Methods， 2011：1-2，19-25.
, 百拇医药
[14] FOO J Y， WAN Y， KOSTNER K， et al. NT-ProBNP levels in saliva and its clinical relevance to heart failure[J]. PLoS One，2012，7(10)：448-452.
[15] DENVER R， TZANIDIS A， MARTINP， et al. Salivary endothelin concentrations in the assessment of chronic heart failure[J].The Lancet， 2000， 9202： 468-469.
[16] GURUSANKAR R， KUMARATHASAN P， SARAVANAMUTHU A， et al. Correlation between Saliva and Plasma Levels of Endothelin Isoforms ET-1， ET-2， and ET-3[J]. Int J Pept，2015：828759.
, http://www.100md.com
[17] PUNYADEERA C. New frontiers in heart failure detection： saliva testing[J]. Bmj Innovations， 2016：bmjinnov-2015-000105.
[18] ZHANG X， SCHULZ B L， PUNYADEERA C. The current status of heart failure diagnostic biomarkers[J]. Expert Review of Molecular Diagnostics， 2016，16(4)：487.
[19] FLORIANO P N， CHRISTODOULIDES N， MILLERCS， et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care： a feasibility study[J]. Clinical chemistry， 2009， 55(8)： 1530-1538.
, 百拇医药
[20] EBERSOLE J L， KRYSCIO R J， CAMPBELL C， et al. Salivary and serum adiponectin and C-reactive protein levels in acute myocardial infarction related to body mass index and oral health[J]. Journal of Periodontal Research， 2016，52(3)：419.
[21] MIRZAII-DIZGAH I， HEJAZI S F， RIAHI E，et al. Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction[J]. Clin Oral Investig，2012，16(3)：775-779.
[22] MILLER C S， RD F J， FLORIANO P N， et al. Utility of salivary biomarkers for demonstrating acute myocardial infarction[J]. Journal of Dental Research， 2014，93(7 Suppl)：72S., 百拇医药(李琳 杜佳 凌智 胡志希 李杰)